FDA Updates Celexa Dosing and Warnings

The Food and Drug Administration clarified dosing and warning recommendations for the SSRI antidepressant Celexa (citalopram hydrobromide) due to the risk of adverse side effects.

In August 2011, the agency announced that Celexa should no longer be used at doses higher than 40 mg per day because it could cause dangerous changes in the electrical activity of the heart or "QT prolongation." The drug label was changed to describe caution that needs to be taken in patients with certain conditions because of the risk of QT prolongation. The new label also describes that patients over 60-years-old, should use lower doses.

In 2011, about 7.2 million patients received a prescription for Celexa from U.S. outpatient retail pharmacies.

If you or a loved one has been harmed by a dangerous drug, contact Sokolove Law for a free legal consultation and to find out if a dangerous drug lawyer may be able to help you.

Tags: